Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4592607 | 0.80 | ALOX15 (0.44) | PARP10CYP2D6PKMTSHRTDP1 | |
| SCHEMBL8731765 | 0.80 | ALOX15 (0.44) | PARP10CYP2D6PKMTSHRTDP1 | |
| SCHEMBL10388997 | 0.79 | ALOX15 (0.45) | PARP10SMN1; SMN2CYP1A2CYP2D6PKM | |
| SCHEMBL4466865 | 0.78 | ALOX15 (0.43) | PARP10CYP2D6PKMTSHRTDP1 | |
| SCHEMBL4010662 | 0.76 | ALDH1A1 (0.43) | PARP10CYP2D6PKMTSHRTDP1 | |
| SCHEMBL247575 | 0.76 | ELANE (0.45) | TSHRTDP1L3MBTL1CYP3A4MAPT | |
| Benzene SCHEMBL9407301 | 0.76 | ELANE (0.45) | TSHRTDP1L3MBTL1CYP3A4MAPT | |
| Carbamic Acid Phenyl Ester SCHEMBL7566 | 0.75 | MEN1 (0.70) | PARP10MEN1KMT2ACTNNB1TSHR | |
| SCHEMBL5244678 | 0.74 | F2 (0.70) | PARP10MEN1KMT2APKMTSHR | |
| Ammonia Solution, Strong SCHEMBL11121327 | 0.74 | ELANE (0.44) | TSHRTDP1L3MBTL1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697376-B1 | SPIRO-CONDENSED INDOLINE DERIVATIVES AS PESTICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-06-18 | — | — | EP | claimed |
| EP-0183174-B1 | SUBSTITUTED PHENOXY UREA, PROCESSES FOR ITS PREPARATION AND HERBICIDE CONTAINING IT AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1988-10-26 | — | — | EP | claimed |
| EP-0183174-A2 | Substituted phenoxy urea, processes for its preparation and herbicide containing it as active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1986-06-04 | — | — | EP | claimed |
| JP-52033640-A | — | — | None | — | — | JP | disclosed |
| CN-109971471-B | Fluorescent carbon dot for detecting phenoxy group-containing carbamate pesticide and application thereof | 中科(大连)快检科技有限公司 | 2022-01-14 | — | — | CN | disclosed |
| EP-2057140-B1 | MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS | ASTRAZENECA AB (SE) | 2012-08-08 | — | — | EP | disclosed |
| US-7750003-B2 | Compounds-943 | ASTRAZENECA AB (SE) | 2010-07-06 | — | — | US | disclosed |
| US-7618717-B2 | Light emitting device | FUJIFILM CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| EP-2057140-A1 | MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS | AstraZeneca AB (SE) | 2009-05-13 | — | — | EP | disclosed |
| US-20080171743-A1 | Transcutaneous immunostimulation | ASTRAZENECA AB (SE) | 2008-07-17 | — | — | US | disclosed |
| WO-2008023159-A1 | MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS | ASTRAZENECA AB (SE) | 2008-02-28 | — | — | WO | disclosed |
| WO-2001042243-A2 | PROTEIN KINASE INHIBITORS | ADVANCED MEDICINE, INC. (US) | 2001-06-14 | — | — | WO | disclosed |
| US-5112385-A | Useful in rice paddies | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0469450-A1 | p-Acylaminophenoxycarbamates and Derivatives | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1992-02-05 | — | — | EP | disclosed |
| US-4968341-A | PRE-AND POSTEMERGENCE HERBICIDES | KUMIAI CHEMICAL INDUSTRY CO. (JP) | 1990-11-06 | — | — | US | disclosed |
| EP-0183174-B1 | SUBSTITUTED PHENOXY UREA, PROCESSES FOR ITS PREPARATION AND HERBICIDE CONTAINING IT AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
| EP-0183174-A2 | Substituted phenoxy urea, processes for its preparation and herbicide containing it as active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1986-06-04 | — | — | EP | disclosed |
| US-4410697-A | CARBAMATE, AMINE, TERTIARY AMINE CATALYST | REANAL FINOMVEGYSZERGYAR (HU) | 1983-10-18 | — | — | US | disclosed |
| WO-1981002156-A1 | PROCESS FOR THE PREPARATION OF N-ARYL-N'-(MONO-OR DISUBSTIUTED)-UREA DERIVATIVES | REANAL FINOMVEGYSZERGYAR (HU) | 1981-08-06 | — | — | WO | disclosed |
| JP-S5233640-A | PROCESS FOR PREPARATION OF BENZENEDICARBOXYLIC ACID AMIDES | BANYU PHARMACEUT CO LTD | 1977-03-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171743-A1 | Transcutaneous immunostimulation | NFATC1, TLR9, MTOR | PARP10 3824/4885MEN1 2336/4885KMT2A 2735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.